3.11
0.32%
-0.01
アフターアワーズ:
3.01
-0.10
-3.22%
前日終値:
$3.12
開ける:
$3.11
24時間の取引高:
32,559
Relative Volume:
0.68
時価総額:
$17.34M
収益:
-
当期純損益:
$-24.47M
株価収益率:
-3.1735
EPS:
-0.98
ネットキャッシュフロー:
$-24.56M
1週間 パフォーマンス:
+5.42%
1か月 パフォーマンス:
+1.97%
6か月 パフォーマンス:
-2.81%
1年 パフォーマンス:
-62.67%
Evaxion Biotech A S Adr Stock (EVAX) Company Profile
Evaxion Biotech A S Adr (EVAX) 最新ニュース
European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - MSN
Evaxion Biotech A/S ADR (EVAX) Stock: From Low to High in 52 Weeks - The InvestChronicle
EVAX’s price-to-cash ratio: Is it a good investment at the moment? - US Post News
Evaxion Biotech Partners With Merck To Expand Vaccine Development - Benzinga
Evaxion Biotech inks vaccine licensing deal with MSD - Investing.com
Evaxion stock jumps on expanded vaccine development pact with MSD (NASDAQ:EVAX) - Seeking Alpha
H.C. Wainwright keeps buy rating on Evaxion stock, cites promising AI-powered cancer vaccine - Investing.com
Evaxion Biotech enhances AI vaccine discovery platform - Investing.com
Evaxion Biotech enhances AI vaccine discovery platform - Investing.com India
Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction - GlobeNewswire Inc.
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - MSN
Evaxion reports promising phase 2 trial results for cancer vaccine - Investing.com
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading - MSN
Evaxion reports high response rate in melanoma trial - Investing.com
Evaxion reports breakthrough in gonorrhea vaccine research - Investing.com
Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2 - GlobeNewswire Inc.
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Edge Lower Friday; Set to End Week Up 0.5% - MSN
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading - MSN
Earnings call: Evaxion Biotech reports Q2 results, optimistic on EVX-01 - Investing.com India
Earnings call: Evaxion Biotech reports Q2 results, optimistic on EVX-01 - Investing.com
Earnings call: Evaxion Biotech reports Q2 results, optimistic on EVX-01 - Investing.com UK
Here's Why Evaxion Biotecch (EVAX) Is a Great 'Buy the Bottom' Stock Now - MSN
European Equities Traded in the US as American Depositary Receipts Move Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday; Set to End Week Down 4% - MSN
European Equities Traded in the US as American Depositary Receipts Trend Lower Thursday - MSN
MSN - MSN
CVB Financial Corp secures key executives with new employment agreements By Investing.com - Investing.com India
Cathie Wood's ARK ETF adjusts portfolio with key stock trades on July 8 By Investing.com - Investing.com
Winmill & Co. buys shares of Bexil Investment Trust worth over $12k By Investing.com - Investing.com
Evaxion Biotech reports progress in AI-powered vaccine development By Investing.com - Investing.com UK
European Equities Traded in the US as American Depositary Receipts Lower Tuesday - MSN
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - MSN
Evaxion Biotech advances in personalized cancer vaccine - Investing.com India
Evaxion Biotech advances in personalized cancer vaccine By Investing.com - Investing.com India
Evaxion Biotech advances in personalized cancer vaccine By Investing.com - Investing.com
Evaxion Biotech advances in personalized cancer vaccine By Investing.com - Investing.com UK
Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel Cancer Vaccine Target Identification Method - GlobeNewswire Inc.
Evaxion Biotech advances in personalized cancer vaccine - Investing.com
Evaxion (EVAX) Enrolls First Patient in Phase IIb Melanoma Study - Yahoo New Zealand News
European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher - MSN
Bank Stocks Help Nudge European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - MSN
Stocks of Evaxion Biotech A/S ADR (EVAX) are poised to climb above their peers - SETE News
Daily Progress: Evaxion Biotech A/S ADR (EVAX) Gain 8.10, Closing at 2.67 - The Dwinnex
Evaxion Biotech A/S ADR (EVAX) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Open Week Slightly Higher in Monday Trading - MSN
Evaxion reports positive results for melanoma vaccine - Investing.com India
Evaxion Biotech A S Adr (EVAX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):